Addressing endogeneity- difference-in-difference analysis
| Before | After | DiD | |
|---|---|---|---|
| Panel A: univariate analysis | |||
| Difference in mean NCSKEWt+1 between treatment and control companies | −0.23** (0.09) | −0.16* (0.01) | −2.36*** (0.43) |
| Difference in mean DUVOLt+1 between treatment and control companies | −0.12** (0.00) | −0.04** (0.00) | −1.42* (0.06) |
| Difference in mean C_COMP between treatment and control companies | 0.43 (1.23) | 0.36* (0.04) | 1.05 (0.00) |
| Difference in mean C_DUAL between treatment and control companies | 0.21* (0.63) | 0.03* (0.02) | −3.48** (0.01) |
| Difference in mean C_STATUS between treatment and control companies | 0.18*** (0.07) | 0.06** (0.00) | −1.13* (0.00) |
| Difference in mean C_TENURE between treatment and control companies | 0.35* (0.00) | 0.27** (0.13) | 2.49* (0.00) |
| Difference in mean C_DIRECTORSHIP between treatment and control companies | 0.22** (0.06) | 0.11* (0.18) | −1.77* (0.00) |
| Before | After | DiD | |
|---|---|---|---|
| Difference in mean NCSKEW | −0.23** (0.09) | −0.16* (0.01) | −2.36*** (0.43) |
| Difference in mean DUVOL | −0.12** (0.00) | −0.04** (0.00) | −1.42* (0.06) |
| Difference in mean C_COMP between treatment and control companies | 0.43 (1.23) | 0.36* (0.04) | 1.05 (0.00) |
| Difference in mean C_DUAL between treatment and control companies | 0.21* (0.63) | 0.03* (0.02) | −3.48** (0.01) |
| Difference in mean C_STATUS between treatment and control companies | 0.18*** (0.07) | 0.06** (0.00) | −1.13* (0.00) |
| Difference in mean C_TENURE between treatment and control companies | 0.35* (0.00) | 0.27** (0.13) | 2.49* (0.00) |
| Difference in mean C_DIRECTORSHIP between treatment and control companies | 0.22** (0.06) | 0.11* (0.18) | −1.77* (0.00) |
| Variable | NCSKEWt+1 | DUVOLt+1 |
|---|---|---|
| Panel B: regression analysis | ||
| TREAT | −0.01 (−1.09) | −0.00 (0.00) |
| POST | 0.46*** (0.02) | 0.08*** (0.01) |
| TREAT*POST | 0.46*** (0.03) | 0.08*** (0.01) |
| DTURNOVER | 0.00 (0.00) | 0.00 (0.00) |
| RET | −78.50*** (2.45) | −0.93*** (0.36) |
| M/B | −0.00 (0.00) | 0.00 (0.00) |
| SIZE | −0.05*** (0.00) | −0.01*** (0.01) |
| LEV | 0.29*** (0.05) | 0.02** (0.01) |
| Constant | 0.56*** (0.13) | 0.08*** (0.02) |
| N | 205 | 205 |
| R2 | 0.73 | 0.65 |
| Year effects | Yes | Yes |
| Industry effects | Yes | Yes |
| Variable | NCSKEW | DUVOL |
|---|---|---|
| TREAT | −0.01 (−1.09) | −0.00 (0.00) |
| POST | 0.46*** (0.02) | 0.08*** (0.01) |
| TREAT*POST | 0.46*** (0.03) | 0.08*** (0.01) |
| DTURNOVER | 0.00 (0.00) | 0.00 (0.00) |
| RET | −78.50*** (2.45) | −0.93*** (0.36) |
| M/B | −0.00 (0.00) | 0.00 (0.00) |
| SIZE | −0.05*** (0.00) | −0.01*** (0.01) |
| LEV | 0.29*** (0.05) | 0.02** (0.01) |
| Constant | 0.56*** (0.13) | 0.08*** (0.02) |
| N | 205 | 205 |
| 0.73 | 0.65 | |
| Year effects | Yes | Yes |
| Industry effects | Yes | Yes |
Note(s): TREAT = binary variable that takes the value of 1 if the company is categorised under the treatment group i.e. the company experienced CEO turnover and 0 if the company is categorised under the control group i.e. the company did not experience any CEO turnover; POST = = binary variable that takes the value of 1 post the CEO turnover period and 0 otherwise; TREAT*POST = an interaction variable between the treatment group and post CEO turnover period; NCSKEWt+1 = negative conditional skewness measured at t+1; DUVOLt+1 = down-to-up-volatility measured at t+1; DTURNOVER = de-trended turnover; RET = company-specific weekly returns; M/B = market to book value of equity; SIZE = size of company measured by taking the natural log of market capitalisation; LEV = leverage. *** and ** indicates the level of significance at 1 and 5% respectively. t-statistics reported in the parentheses are based on robust standard errors. Difference-in-Difference panel data regression methodology has been applied to obtain the said test results
Source(s): Author’s calculations based on using Stata 14
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.